Article
Enhancing the anti-tumor response by combining DNA damage repair inhibitors in the treatment of solid tumors
10 May 2023
Abstract excerpt
The anti-cancer efficacy of anti-malignancy therapies is related to DNA damage. However, DNA damage-response mechanisms can repair DNA damage, failing anti-tumor therapy. The resistance to chemotherapy, radiotherapy, and immunotherapy remains a clinical challenge. Thus, new strategies to overcome these therapeutic resistance mechanisms are needed. DNA damage repair inhibitors (DDRis) continue to be investigated,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
